Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges in nodal peripheral T-cell lymphomas: from biological advances to clinical applicability. | Front Oncol | 2023 | 37188189 | PubTator, text mining | PubMed |
| Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses. | Front Oncol | 2023 | 37188172 | PubTator, text mining | PubMed |
| Molecular characterization of sub-frontal recurrent medulloblastomas reveals potential clinical relevance. | Front Neurol | 2023 | 37181548 | PubTator, text mining | PubMed |
| Role of brahma-related gene 1/brahma-associated factor subunits in neural stem/progenitor cells and related neural developmental disorders. | World J Stem Cells | 2023 | 37181007 | PubTator, text mining | PubMed |
| Genetic Predisposition to Hematologic Malignancies in Childhood and Adolescence. | Mediterr J Hematol Infect Dis | 2023 | 37180200 | PubTator, text mining | PubMed |
| RNA-seq analysis identifies transcriptomic profiles associated with anal cancer recurrence among people living with HIV. | Ann Med | 2023 | 37177979 | PubTator, text mining | PubMed |
| The State of Research and Weight of Evidence on the Epigenetic Effects of Bisphenol A. | Int J Mol Sci | 2023 | 37175656 | PubTator, text mining | PubMed |
| Mutational Landscape of Cholangiocarcinoma According to Different Etiologies: A Review. | Cells | 2023 | 37174616 | PubTator, text mining | PubMed |
| Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival. | Function (Oxf) | 2023 | 37168490 | PubTator, text mining | PubMed |
| Epigenotype-genotype-phenotype correlations in SETD1A and SETD2 chromatin disorders. | Hum Mol Genet | 2023 | 37166351 | PubTator, text mining | PubMed |
| A familial SAMD9 variant present in pediatric myelodysplastic syndrome. | Cold Spring Harb Mol Case Stud | 2023 | 37160314 | PubTator, text mining | PubMed |
| Systematic integration of protein-affecting mutations, gene fusions, and copy number alterations into a comprehensive somatic mutational profile. | Cell Rep Methods | 2023 | 37159661 | PubTator, text mining | PubMed |
| Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. | Ann Gastroenterol Surg | 2023 | 37152777 | PubTator, text mining | PubMed |
| Bayesian network enables interpretable and state-of-the-art prediction of immunotherapy responses in cancer patients. | PNAS Nexus | 2023 | 37152678 | PubTator, text mining | PubMed |
| A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. | Dev Cell | 2023 | 37148882 | PubTator, text mining | PubMed |
| Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going? | Curr Treat Options Oncol | 2023 | 37145382 | PubTator, text mining | PubMed |
| Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics. | Cancer Res | 2023 | 37145128 | PubTator, text mining | PubMed |
| Circulating Cell-Free Tumor Deoxyribonucleic Acid Analysis as a Tool for the Diagnosis and Monitoring of Pediatric Solid Tumors. | Turk Arch Pediatr | 2023 | 37144257 | PubTator, text mining | PubMed |
| KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. | Adv Sci (Weinh) | 2023 | 37142882 | PubTator, text mining | PubMed |
| Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer. | Oncoimmunology | 2023 | 37139184 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=33